Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [9503]
News [23297]
Articles [1985]
Editorials [134]
Conferences [463]
elearning [298]
Lung cancer patients lacking MSH2 DNA repair protein fare better with chemo
Dr Pierre Fouret - Institut Gustave Roussy, France
Lung cancer patients lacking MSH2 DNA repair protein fare better with chemo ( Dr Pierre Fouret - Institut Gustave Roussy, France )
3 Jul 2009
Targeting death receptors in chemo-resistant cancer cells
Prof Patrick Johnston - Queen's University Belfast, UK
Targeting death receptors in chemo-resistant cancer cells ( Prof Patrick Johnston - Queen's University Belfast, UK )
3 Jul 2009
Treatment based on rising CA125 blood levels does not improve survival for...
Dr Gordon Rustin - Mount Vernon Cancer Center, UK
Treatment based on rising CA125 blood levels does not improve survival for recurrent ovarian cancer ( Dr Gordon Rustin - Mount Vernon Cancer Center, UK )
3 Jul 2009
Sentinel node biopsy is effective, less invasive option for early-stage...
Dr Fabrice Lecuru - George Pompidou European Hospital, France
Sentinel node biopsy is effective, less invasive option for early-stage cervical cancer patients ( Dr Fabrice Lecuru - George Pompidou European Hospital, France )
3 Jul 2009
Standard treatment plus trastuzumab for HER2+ gastric cancer
Dr Eric Van Cutsem - University Hospital Gasthuisberg, Belgium
Standard treatment plus trastuzumab for HER2+ gastric cancer ( Dr Eric Van Cutsem - University Hospital Gasthuisberg, Belgium )
3 Jul 2009
Olaparib induces tumour response as single agent in BRCA-deficient breast cancer
Dr Andrew Tutt - Breakthrough Breast Cancer Research Unit, Kings College London...
Olaparib induces tumour response as single agent in BRCA-deficient breast cancer ( Dr Andrew Tutt - Breakthrough Breast Cancer Research Unit, Kings College London, UK )
3 Jul 2009
PARP inhibitor BS-201 plus chemotherapy: new option for triple-negative breast...
Dr Joyce O'Shaughnessy - Baylor-Charles A. Sammons Cancer Center, US
PARP inhibitor BS-201 plus chemotherapy: new option for triple-negative breast cancer ( Dr Joyce O'Shaughnessy - Baylor-Charles A. Sammons Cancer Center, US )
3 Jul 2009
Therapeutic vaccine improves response rate and extends progression-free...
Dr Patrick Hwu - M.D. Anderson Cancer Center, US
Therapeutic vaccine improves response rate and extends progression-free survival in patients with metastatic melanoma ( Dr Patrick Hwu - M.D. Anderson Cancer Center, US )
3 Jul 2009
Bortezomib based therapies for myeloma
Dr Paul Richardson - Hematologic Oncology Dept, Dana-Farber Cancer Institute
Bortezomib based therapies for myeloma ( Dr Paul Richardson - Hematologic Oncology Dept, Dana-Farber Cancer Institute )
2 Jul 2009
Therapeutic cancer vaccine significantly prolongs disease-free survival for...
Dr Stephen Schuster - University of Pennsylvania School of Medicine, USA
Therapeutic cancer vaccine significantly prolongs disease-free survival for follicular lymphoma ( Dr Stephen Schuster - University of Pennsylvania School of Medicine, USA )
2 Jul 2009
PARP inhibitors show promise for hard-to-treat breast cancers
Dr. Andrew Tutt - Breakthrough Breast Cancer Research Unit, Kings College...
PARP inhibitors show promise for hard-to-treat breast cancers ( Dr. Andrew Tutt - Breakthrough Breast Cancer Research Unit, Kings College London, UK )
25 Jun 2009
Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
Dr. Jacek Gronwald, International Hereditary Cancer Centre, Poland
Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients ( Dr. Jacek Gronwald, International Hereditary Cancer Centre, Poland )
25 Jun 2009

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation